HOT-7
| 
 | |
| Names | |
|---|---|
| 
Preferred IUPAC name
 2-[2,5-Dimethoxy-4-(propylsulfanyl)phenyl]-N-hydroxyethan-1-amine  | |
| Other names
 2-[4-(Propylthio)-2,5-dimethoxyphenyl]ethanaminol 
 | |
| Identifiers | |
| 
 3D model (JSmol) 
 | 
|
| ChEMBL | |
| ChemSpider | 
  | 
| 
 
PubChem CID
 
 | 
|
| UNII | |
| 
 
CompTox Dashboard (EPA)
 
 | 
|
  | |
  | |
| Properties | |
| C13H21NO3S | |
| Molar mass | 271.374 g/mol | 
| 
 Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
 | |
HOT-7, or 2,5-dimethoxy-4-(β-propylthio)-N-hydroxyphenethylamine, is a psychedelic phenethylamine of the 2C family. It was presumably first synthesized by Alexander Shulgin and reported in his book, PiHKAL.
Chemistry
HOT-7's full chemical name is 2-[4-(2-propylthio)-2,5-dimethoxyphenyl–N–hydroxyethanamine. It has structural properties similar to 2C-T-7 and to other drugs in the HOT- series, with the most closely related compounds being HOT-2 and HOT-17.
General information
The dosage range of HOT-7 is typically 15-25 mg and its duration is approximately 6–8 hours according to Shulgin. HOT-7 produces closed-eye and open-eye visuals. It also induces a feeling similar to that of being drunk.
Legality
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.
See also
  |